tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Promising Future for Praxis Precision Medicines: Buy Rating Based on Robust Pipeline and Market Opportunities
PremiumRatingsPromising Future for Praxis Precision Medicines: Buy Rating Based on Robust Pipeline and Market Opportunities
12d ago
Praxis Precision initiated with a Buy at BTIG
Premium
The Fly
Praxis Precision initiated with a Buy at BTIG
12d ago
Optimistic Outlook for Praxis Precision Medicines: Promising Drug Pipeline and Strategic Advancements Drive Buy Rating
Premium
Ratings
Optimistic Outlook for Praxis Precision Medicines: Promising Drug Pipeline and Strategic Advancements Drive Buy Rating
18d ago
Praxis Precision Medicines Reports Q3 2025 Financial Results
PremiumCompany AnnouncementsPraxis Precision Medicines Reports Q3 2025 Financial Results
25d ago
Positive Phase 3 Trial Results and Strong Financial Position Drive Buy Rating for Praxis Precision Medicines
Premium
Ratings
Positive Phase 3 Trial Results and Strong Financial Position Drive Buy Rating for Praxis Precision Medicines
25d ago
Praxis Precision Medicines: Buy Rating Affirmed on Promising Phase III Results and Market Potential
Premium
Ratings
Praxis Precision Medicines: Buy Rating Affirmed on Promising Phase III Results and Market Potential
25d ago
Praxis Precision Medicines: Buy Rating Backed by Accelerated FDA Approval Path and Promising Relutrigine Data
PremiumRatingsPraxis Precision Medicines: Buy Rating Backed by Accelerated FDA Approval Path and Promising Relutrigine Data
27d ago
Praxis Precision reaches alignment with FDA for relutrigine program
Premium
The Fly
Praxis Precision reaches alignment with FDA for relutrigine program
27d ago
Praxis Precision Medicines Advances Elsunersen Trial for Pediatric Epileptic Encephalopathy
Premium
Company Announcements
Praxis Precision Medicines Advances Elsunersen Trial for Pediatric Epileptic Encephalopathy
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100